NPI: 1396792032 · FLOWOOD, MS 39232 · General Acute Care Hospital · NPI assigned 05/28/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR) |
| NPI Enumeration Date | 05/28/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 74,379 | $2.94M |
| 2019 | 68,252 | $2.97M |
| 2020 | 61,931 | $1.99M |
| 2021 | 74,604 | $2.33M |
| 2022 | 98,424 | $2.62M |
| 2023 | 88,385 | $2.18M |
| 2024 | 55,196 | $1.56M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 27,816 | 20,726 | $3.31M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 12,674 | 9,464 | $2.03M |
| G0378 | Hospital observation service, per hour | 4,487 | 3,047 | $1.03M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1,151 | 631 | $788K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8,029 | 6,298 | $602K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7,699 | 5,642 | $585K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,997 | 2,252 | $576K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 11,064 | 2,893 | $496K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2,970 | 2,238 | $472K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 11,202 | 2,561 | $444K |
| D7140 | Extraction, erupted tooth or exposed root | 1,029 | 278 | $393K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 8,303 | 6,356 | $336K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 6,931 | 1,145 | $335K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,555 | 1,917 | $325K |
| 87428 | 6,082 | 4,594 | $267K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 8,128 | 5,787 | $267K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 129 | 82 | $266K |
| 96361 | Intravenous infusion, hydration; each additional hour | 5,156 | 3,420 | $262K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1,725 | 1,446 | $248K |
| 71046 | Radiologic examination, chest; 2 views | 5,987 | 4,576 | $201K |
| 71045 | Radiologic examination, chest; single view | 5,705 | 4,173 | $194K |
| 86900 | 4,012 | 2,927 | $171K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 9,727 | 6,953 | $155K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,864 | 2,142 | $132K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,614 | 1,228 | $131K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,507 | 1,149 | $129K |
| 96375 | Therapeutic injection; each additional sequential IV push | 4,806 | 3,343 | $106K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3,738 | 3,039 | $106K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 24,086 | 16,097 | $105K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7,399 | 5,690 | $102K |
| 80053 | Comprehensive metabolic panel | 15,906 | 11,535 | $94K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 878 | 542 | $93K |
| 87641 | 5,150 | 3,801 | $91K | |
| D2934 | 1,281 | 310 | $90K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4,474 | 3,234 | $88K |
| 74018 | 2,082 | 1,544 | $77K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,922 | 1,489 | $74K |
| 87430 | 5,924 | 4,648 | $65K | |
| 86850 | 3,324 | 2,401 | $60K | |
| 36415 | Collection of venous blood by venipuncture | 31,526 | 20,292 | $58K |
| 86901 | 4,018 | 2,929 | $52K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 518 | 360 | $43K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 692 | 521 | $43K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 361 | 153 | $41K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,408 | 1,077 | $41K |
| 84703 | 8,005 | 6,085 | $40K | |
| 76801 | 620 | 478 | $39K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 6,820 | 5,052 | $38K |
| 97161 | 1,103 | 746 | $37K | |
| 73560 | 1,117 | 802 | $35K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 7,353 | 4,979 | $35K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 173 | 115 | $33K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1,544 | 456 | $33K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,843 | 2,247 | $31K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,206 | 440 | $27K |
| 81001 | 13,869 | 10,133 | $26K | |
| 87070 | 4,043 | 3,184 | $26K | |
| 73610 | 682 | 505 | $26K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,757 | 1,256 | $26K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 267 | 236 | $26K |
| 84484 | 3,843 | 2,379 | $25K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 478 | 323 | $24K |
| 80061 | Lipid panel | 2,730 | 2,130 | $24K |
| 88720 | 6,058 | 4,473 | $22K | |
| 94762 | 486 | 300 | $22K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,000 | 3,080 | $20K |
| 92526 | 424 | 156 | $20K | |
| 73630 | 489 | 373 | $19K | |
| 84702 | 2,019 | 1,471 | $19K | |
| 83690 | 3,623 | 2,680 | $16K | |
| 83880 | 1,037 | 704 | $16K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 629 | 166 | $14K |
| 73221 | 107 | 84 | $12K | |
| 72100 | 244 | 167 | $10K | |
| 81003 | 6,346 | 4,729 | $10K | |
| G0379 | Direct admission of patient for hospital observation care | 214 | 148 | $9K |
| 72141 | 114 | 87 | $9K | |
| 85730 | 3,486 | 2,451 | $9K | |
| 87186 | 1,409 | 1,089 | $8K | |
| 81025 | 1,664 | 1,220 | $8K | |
| 85610 | 4,325 | 3,040 | $8K | |
| 73130 | 182 | 133 | $7K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 389 | 130 | $7K |
| 87077 | 1,328 | 1,027 | $7K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 255 | 213 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 254 | 212 | $7K |
| 82962 | 3,831 | 1,669 | $7K | |
| 87807 | 669 | 553 | $7K | |
| D2330 | 311 | 132 | $6K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,550 | 1,060 | $6K |
| 97116 | 991 | 438 | $6K | |
| 92523 | 40 | 37 | $6K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 155 | 128 | $6K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 129 | 89 | $5K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 10,542 | 7,457 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,085 | 853 | $5K |
| 73030 | 161 | 119 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 150 | 119 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,525 | 3,373 | $5K |
| 83605 | 894 | 605 | $5K | |
| 87040 | 800 | 405 | $5K | |
| 72131 | 125 | 106 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 11,259 | 7,884 | $4K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 2,432 | 1,687 | $4K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 7,677 | 5,218 | $4K |
| 72040 | 124 | 82 | $4K | |
| 82247 | 1,209 | 637 | $4K | |
| 85014 | 2,580 | 1,914 | $4K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 5,595 | 3,723 | $3K |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 3,070 | 2,084 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 261 | 192 | $3K |
| J2704 | Injection, propofol, 10 mg | 7,913 | 5,591 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 9,156 | 6,365 | $3K |
| 85652 | 947 | 733 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 10,041 | 7,116 | $3K |
| J0690 | Injection, cefazolin sodium, 500 mg | 5,481 | 3,523 | $3K |
| 86140 | 868 | 605 | $3K | |
| 74019 | 50 | 37 | $3K | |
| 83735 | 985 | 628 | $3K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 28 | 24 | $3K |
| 82540 | 736 | 584 | $2K | |
| 73110 | 77 | 56 | $2K | |
| 84132 | 848 | 673 | $2K | |
| 82607 | 369 | 257 | $2K | |
| 93971 | 72 | 52 | $2K | |
| 84439 | 318 | 246 | $2K | |
| 93970 | 27 | 25 | $2K | |
| 82728 | 249 | 156 | $1K | |
| 87205 | 424 | 283 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3,083 | 2,147 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 16 | 13 | $1K |
| 97165 | 37 | 29 | $1K | |
| 76830 | Ultrasound, transvaginal | 24 | 15 | $1K |
| 85027 | 468 | 359 | $919.74 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 234 | 185 | $900.35 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 22 | 13 | $872.61 |
| 84520 | 310 | 256 | $830.40 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 24 | 15 | $768.36 |
| 85018 | 704 | 502 | $765.22 | |
| 93041 | 86 | 49 | $738.19 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 364 | 246 | $706.91 |
| 84550 | 221 | 161 | $658.54 | |
| 82731 | 16 | 12 | $595.12 | |
| 97162 | 13 | 12 | $589.46 | |
| 72110 | 21 | 12 | $551.14 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 4,653 | 3,268 | $515.88 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 35 | 24 | $448.50 |
| 84450 | 149 | 104 | $445.72 | |
| 85379 | 68 | 53 | $383.09 | |
| 93979 | 20 | 12 | $344.36 | |
| 82550 | 101 | 67 | $343.30 | |
| 82565 | 261 | 146 | $328.76 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 18 | 13 | $323.40 |
| J1170 | Injection, hydromorphone, up to 4 mg | 4,223 | 2,702 | $281.81 |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 2,022 | 1,418 | $270.02 |
| 82947 | 230 | 145 | $261.65 | |
| 83540 | 105 | 53 | $241.62 | |
| 80076 | 39 | 27 | $223.77 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 7,111 | 4,965 | $177.99 |
| 86780 | 18 | 13 | $145.77 | |
| 82746 | 56 | 25 | $127.02 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 369 | 238 | $125.85 |
| 82570 | 38 | 25 | $103.95 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 48 | 31 | $84.72 |
| 83615 | 14 | 12 | $76.46 | |
| 87147 | 14 | 12 | $67.15 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 1,834 | 1,240 | $53.22 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 69 | 51 | $39.81 |
| J3370 | Injection, vancomycin hcl, 500 mg | 954 | 559 | $17.16 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 1,361 | 873 | $7.44 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 496 | 358 | $3.10 |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 196 | 145 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 104 | 75 | $0.00 |
| C1758 | Catheter, ureteral | 841 | 581 | $0.00 |
| 94664 | 436 | 312 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 233 | 181 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 894 | 607 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 148 | 83 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 83 | 67 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 265 | 189 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 952 | 571 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 131 | 87 | $0.00 |
| 99152 | 293 | 207 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 199 | 152 | $0.00 |
| C1776 | Joint device (implantable) | 109 | 64 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 49 | 36 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 48 | 37 | $0.00 |
| C1762 | Connective tissue, human (includes fascia lata) | 80 | 50 | $0.00 |
| G1002 | Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program | 29 | 25 | $0.00 |
| 90714 | 21 | 12 | $0.00 | |
| J0595 | Injection, butorphanol tartrate, 1 mg | 23 | 13 | $0.00 |
| 96376 | 1,414 | 814 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 463 | 319 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 446 | 275 | $0.00 |
| C1769 | Guide wire | 292 | 220 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 3,522 | 2,524 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 380 | 276 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 43 | 32 | $0.00 |
| 90378 | 266 | 195 | $0.00 | |
| J3490 | Unclassified drugs | 170 | 85 | $0.00 |
| 97535 | Self-care/home management training, each 15 minutes | 160 | 82 | $0.00 |
| 0240U | 128 | 102 | $0.00 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 109 | 74 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 67 | 50 | $0.00 |
| 96111 | 144 | 69 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 33 | 24 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 36 | 28 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 20 | 12 | $0.00 |
| 80349 | 18 | 13 | $0.00 | |
| 94760 | 27 | 25 | $0.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 25 | 15 | $0.00 |